1 Laboratory of Neuroanatomy of the Peptidergic Systems, Institute of Neurosciences of Castilla and León (INCYL), University of Salamanca, 37007 Salamanca, Spain.
2 Group GIR-USAL: BMD (Bases Moleculares del Desarrollo), University of Salamanca, 37007 Salamanca, Spain.
3 Pediatric Intensive Care Unit, Virgen del Rocío University Hospital, Avda. Manuel Siurot s/n, 41013 Seville, Spain.
4 Research Laboratory on Neuropeptides, Institute of Biomedicine of Seville (IBIS), 41013 Seville, Spain.
New, promising molecular targets to block tumor development and new compounds capable of specifically destroying cancer cells must be urgently investigated [...].